---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-035483"
form_type: "8-K"
ticker: "COCH"
cik: "0001840877"
company_name: "Envoy Medical, Inc."
filed_at: "2026-03-27T23:59:59+00:00"
generated_at: "2026-05-15T08:41:15.605129+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Envoy Medical reports FY2025 revenue $241k; extinguishes $32M debt; completes Acclaim trial enrollment

## Summary
- FY2025 net revenue $241k, up from $225k (YoY +$16k). No EPS given.
- Extinguished over $32M of debt in 2025; cash $3.7M at year-end.
- FDA approved expansion of Acclaim cochlear implant pivotal trial to final stage.
- Post year-end: closed up to $78M public offering ($30M received); enrolled 56-patient pivotal trial.
- IP portfolio grew to 47 patents globally.

## SEC filing metadata
- accession: 0001213900-26-035483
- form_type: 8-K
- ticker: COCH
- cik: 0001840877
- company_name: Envoy Medical, Inc.
- filed_at: 2026-03-27T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840877/000121390026035483/0001213900-26-035483-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840877/000121390026035483/ea0283065-8k_envoy.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-035483
- JSON: https://secwatch.observer/filing/0001213900-26-035483.json
- Plain text: https://secwatch.observer/filing/0001213900-26-035483.txt

## Key facts
- Earnings Releases
  Envoy Medical, Inc. reported full year ended December 31, 2025 results: revenue $241.
  - Period: full year ended December 31, 2025
  - Revenue: $241
  - Result: reported results
  source text: Net Revenue was $241 as of December 31, 2025 compared to $225 for year ended December 31, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1840877/000121390026035483/0001213900-26-035483-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.